| Literature DB >> 23771846 |
Petra Laššuthová1, Markéta Žaliová2, Ken Inoue3, Jana Haberlová4, Klára Sixtová5, Iva Sakmaryová4, Kateřina Paděrová4, Radim Mazanec6, Josef Zámečník7, Dana Šišková5, Jim Garbern8, Pavel Seeman4.
Abstract
Pelizaeus-Merzbacher disease is a severe X-linked disorder of central myelination caused by mutations affecting the proteolipid protein gene. We describe 3 new PLP1 splicing mutations, their effect on splicing and associated phenotypes. Mutation c.453_453+6del7insA affects the exon 3B donor splice site and disrupts the PLP1-transcript without affecting the DM20, was found in a patient with severe Pelizaeus-Merzbacher disease and in his female cousin with early-onset spastic paraparesis. Mutation c.191+1G>A causes exon 2 skipping with a frame shift, is expected to result in a functionally null allele, and was found in a patient with mild Pelizaeus-Merzbacher disease and in his aunt with late-onset spastic paraparesis. Mutation c.696+1G>A utilizes a cryptic splice site in exon 5, causes partial exon 5 skipping and in-frame deletion, and was found in an isolated patient with a severe classical Pelizaeus-Merzbacher. PLP1 splice-site mutations express a variety of disease phenotypes mediated by different molecular pathogenic mechanisms.Entities:
Keywords: PLP1; Pelizaeus-Merzbacher disease; splice-site mutations
Mesh:
Substances:
Year: 2013 PMID: 23771846 DOI: 10.1177/0883073813492387
Source DB: PubMed Journal: J Child Neurol ISSN: 0883-0738 Impact factor: 1.987